CA2143629A1 - Acides gras satures x-hydroxyles pour le traitement de la corne et des callosites - Google Patents

Acides gras satures x-hydroxyles pour le traitement de la corne et des callosites

Info

Publication number
CA2143629A1
CA2143629A1 CA002143629A CA2143629A CA2143629A1 CA 2143629 A1 CA2143629 A1 CA 2143629A1 CA 002143629 A CA002143629 A CA 002143629A CA 2143629 A CA2143629 A CA 2143629A CA 2143629 A1 CA2143629 A1 CA 2143629A1
Authority
CA
Canada
Prior art keywords
alpha
fatty acid
saturated
hydroxy
hydroxy fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002143629A
Other languages
English (en)
Inventor
Michael L. Caswell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Consumer Care Holdings LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2143629A1 publication Critical patent/CA2143629A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
CA002143629A 1992-09-02 1993-08-20 Acides gras satures x-hydroxyles pour le traitement de la corne et des callosites Abandoned CA2143629A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93928292A 1992-09-02 1992-09-02
US07/939,282 1992-09-02

Publications (1)

Publication Number Publication Date
CA2143629A1 true CA2143629A1 (fr) 1994-03-17

Family

ID=25472877

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002143629A Abandoned CA2143629A1 (fr) 1992-09-02 1993-08-20 Acides gras satures x-hydroxyles pour le traitement de la corne et des callosites

Country Status (6)

Country Link
EP (1) EP0658108A1 (fr)
JP (1) JPH08500603A (fr)
AU (1) AU5016393A (fr)
CA (1) CA2143629A1 (fr)
MX (1) MX9305345A (fr)
WO (1) WO1994005278A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8620896D0 (en) * 1986-08-29 1986-10-08 Unilever Plc Cosmetic composition
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
JPH02283799A (ja) * 1989-04-24 1990-11-21 Lion Corp 洗浄剤

Also Published As

Publication number Publication date
MX9305345A (es) 1994-03-31
JPH08500603A (ja) 1996-01-23
AU5016393A (en) 1994-03-29
EP0658108A1 (fr) 1995-06-21
WO1994005278A1 (fr) 1994-03-17

Similar Documents

Publication Publication Date Title
EP0086070B1 (fr) Composition pour le traitement de la peau
US4588590A (en) Method of treating keratosis and compositions useful therefor
US6008254A (en) Method of treating skin disorders with high-strength tretinoin
JPH1045533A (ja) レチノール長鎖不飽和脂肪酸エステルを有する化粧品組成物
JPH085785B2 (ja) 魚鱗癬の治療剤
WO2000000186A1 (fr) Procede de traitement des troubles topiques
JP2000513706A (ja) スキンケア製剤とその方法
US20030104018A1 (en) Skin product having micro-spheres, and processes for the production thereof
US5444091A (en) Method of applying alpha hydroxy acids for treating striae distensae
Rubin Trichloroacetic acid and other non-phenol peels
Statham et al. Short‐contact dithranol therapy—a comparison with the Ingram regime
DK165938B (da) Topisk middel til behandling af non-inflammatorisk acne
CA2143629A1 (fr) Acides gras satures x-hydroxyles pour le traitement de la corne et des callosites
EP0415458B1 (fr) Utilisation des rétinoids pour la prévention et la diminuation des striae distensae
JPH09110627A (ja) 皮膚の剥離促進もしくは表皮更新の刺激のためのシステイン酸またはホモシステイン酸を含む組成物
CA2294067A1 (fr) Dispositif d'administration d'ingredients dermatologiques
SMITH et al. Resin of Podophyllum in Treatment of Cancerous and Precancerous Conditions of Skin: Effect on Basal Cell Epithelioma and Seborrheic, Senile and Radiation Keratoses
JPH01502907A (ja) 主に皮膚科学および化粧料用のエステラーゼ産生微生物抑制剤
EP0149600B1 (fr) Compositions pour le traitement de la keratose
JP2006321778A (ja) 皮膚修復用組成物及びそれを用いた皮膚修復剤
EP0448213B1 (fr) L'utilisation des rétinoides pour amoindrir les endommagements de la peau
NO178457C (no) Fremgangsmåte for fremstilling av et salisylsyreholdig preparat for behandling av hudsykdommer med avskalling
Stauffer Skin disorders in athletes: identification and management
DE69013139T2 (de) Mittel zur Vorbeugung, Diagnose und Therapie von rheumatischen, autoimmunen, Haut- und Bindegewebekrankheiten von unbekannter Aetiologie und Verfahren zu seiner Herstellung und Verwendung.
JPS58134009A (ja) 皮膚処理用組成物

Legal Events

Date Code Title Description
FZDE Dead